Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

New NSAID from Maruho and Toyama (M-5011) compares favorably with known compounds

Feb. 16, 1998

Pharmacokinetic/pharmacodynamic characterization of CP-105696 in volunteers

Feb. 13, 1998

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Feb. 12, 1998

New antiinflammatory agents prepared by Brazilian academics

Feb. 11, 1998

Idec evaluates humanized anti-gp39 antibody in phase I

Feb. 11, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Positive preclinical results reported for IPL-423

Feb. 10, 1998

Several related series of MMP inhibitors claimed by Bayer

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...